Natco Pharma Nine Monthly Results

FINANCIALS

Select Period:

Particulars ( Rupees In Crores.)	Dec-2022	Dec-2021	Dec-2020	Dec-2019	Dec-2018
Gross Sales	1809.20	1,348	1720.80	1460.20	1638.80
Excise Duty	--	--	--	--	--
Net Sales	1809.20	1,348	1720.80	1460.20	1638.80
Other Operating Income	--	--	--	--	--
Other Income	75.60	85.20	75.20	85	99.20
Total Income	1884.80	1433.20	1,796	1545.20	1,738
Total Expenditure	1212.70	1065.90	1190.80	1005.90	992.30
PBIDT	672.10	367.30	605.20	539.30	745.70
Interest	11.80	11	9.80	18	14.10
PBDT	660.30	356.30	595.40	521.30	731.60
Depreciation	122.80	104.50	86.50	69.30	59.30
Minority Interest Before NP	--	--	--	--	--
Tax	104.40	48.40	122	104.90	171.30
Deferred Tax	(6.40)	(17.10)	(2.50)	(17.80)	(21)
Reported Profit After Tax	439.50	220.50	389.40	364.90	522
Minority Interest After NP	--	--	1.50	(1.80)	(1.60)
Net Profit after Minority Interest	439.50	220.50	387.90	366.70	523.60
Extra-ordinary Items	--	--	--	--	--
Adjusted Profit After Extra-ordinary item	439.50	220.50	387.90	366.70	523.60
EPS (Unit Curr.)	24.08	12.09	21.39	20.16	28.38
Book Value (Unit Curr.)	--	--	--	--	--
Dividend (%)	275	225	262.50	237.50	250
Equity	36.50	36.50	36.40	36.40	36.80
Public Shareholding (Number)	--	--	--	--	--
Public Shareholding (%)	--	--	--	--	--
Pledged/Encumbered - No. of Shares	--	--	--	--	--
Pledged/Encumbered - % in Total Promoters Holding	--	--	--	--	--
Pledged/Encumbered - % in Total Equity	--	--	--	--	--
Non Encumbered - No. of Shares	--	--	--	--	--
Non Encumbered - % in Total Promoters Holding	--	--	--	--	--
Non Encumbered - % in Total Equity	--	--	--	--	--
PBIDTM(%)	37.15	27.25	35.17	36.93	45.50
PBDTM(%)	36.50	26.43	34.60	35.70	44.64
PATM(%)	24.29	16.36	22.63	24.99	31.85

QuickLinks for Natco Pharma Ltd.